Tuesday, March 26, 2013

International Stem Cell Corp. (ISCO) Schedules Conference Call to Discuss Financial Results and Update Investors

International Stem Cell Corp., a biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), today announced that it will be hosting a conference call this week to discuss its 2012 financial results as well as provide a business update.

Dr. Simon Craw, Executive Vice President, and Ms. Linh Nguyen, Chief Financial Officer of International Stem Cell, will host the conference call. Those who wish to participate should use the dial-in information below.

Date: Thursday March 28, 2013
Time: 11:00 a.m. ET
Conference Line (U.S.): 1-877-941-2068
International Dial-In: 1-480-629-9712
Conference ID: 4610666
Webcast: http://public.viavid.com/player/index.php?id=104040

ISCO recommends logging in at least 10 minutes before the call start time. A playback of the call will be available shortly after its conclusion. Replay information can be found below.

Teleconference Replay Details:
US Domestic: 1-877-870-5176
International: 1-858-384-5517
Conference ID: 4610666

To learn more about International Stem Cell Corp., visit www.internationalstemcell.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: